Trial Profile

Pharmacodynamic Effects of a Free-fatty Acid Formulation of Omega-3 Pentaenoic Acid to ENHANCE Efficacy in Adults With Hypertriglyceridemia: The ENHANCE-IT Trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 08 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ethyl eicosapentaenoic acid (Primary)
Indications Hypertriglyceridaemia
Focus Pharmacodynamics
Acronyms ENHANCE-IT
Sponsors Matinas BioPharma

Most Recent Events

22 Feb 2021 Planned End Date changed from 1 Mar 2021 to 1 Jun 2021.
22 Feb 2021 Planned primary completion date changed from 1 Dec 2020 to 1 May 2021.
01 Feb 2021 According to a Matinas BioPharma media release, the company will host a live conference call and webcast on 1st February 2021 to discuss trial results. A slide presentation will accompany the call and webcast and will be available on the Company's website.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com